Evidence map›Paper›PMID 42666310›Full record

ArticleFrontiers in bioengineering and biotechnology2026

Gold nanoparticle-based colorimetric detection of ATP via a label-free aptamer.

Wenxiu Dai, Qingqin Hao

Abstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wenxiu DaiDepartment of Clinical Laboratory, Wuxi Blood Center, Wuxi, China.
Qingqin HaoDepartment of Clinical Laboratory, Wuxi Blood Center, Wuxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine triphosphate (ATP) is an important detection content in many biological reaction detection. At present, the detection methods of ATP mainly focused on electrophoresis, optical analysis, chromatography, and bioluminescence. However, these methods are not widely applied due to the high cost, complicated operation, time-consuming and low sensitivity. Here we developed a simple, fast and sensitive ATP biosensor with the specific aptamer as the recognition element and the unmodified gold nanoparticle (AuNPs) as the colorimetric probe. In the high salt environment, the aggregation of AuNPs causes the color change from red to blue. However, in the presence of aptamer, the free aptamers protect the AuNPs from aggregation and keeps the color of the solution red. Conversely, in the presence of ATP, aptamers are consumed to form aptamer-ATP complex, the AuNPs lose their protection and aggregate with the visual color change from red to blue. Our results show that ATP with a linear range of 5-320 μM can be detected. In conclusion, nanoparticles-based colorimetric method is feasible for ATP detection and has great potential in clinical screening.

Indexed as

aptamerATPbiosensorcolorimetrygold nanoparticles

Identifiers

PMID42666310
PMCPMC13522182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.